What is Pentasa 500 mg?
Pentasa 500 mg is a brand of mesalazine (5-aminosalicylic acid, 5-ASA) used to treat inflammatory bowel disease, most commonly ulcerative colitis and sometimes Crohn’s disease (depending on the country and indication). The “500 mg” refers to the dose strength of the mesalazine drug product.
What does Pentasa treat?
Mesalazine is an anti-inflammatory medicine that acts locally in the gut. Pentasa is used for:
- Ulcerative colitis (to induce and/or maintain remission, depending on regimen)
- Crohn’s disease in specific cases (often for maintenance in certain patient groups, depending on local prescribing guidance)
How is Pentasa 500 mg usually taken?
Pentasa is commonly prescribed as oral tablets or sachets (formulation varies by region). The key practical point is that dosing depends on whether it’s for active disease or maintenance, and on the patient’s age and severity. Follow the exact instructions on your prescription label or clinician’s directions.
What side effects are associated with mesalazine (Pentasa)?
Common side effects reported with mesalazine medicines can include headache, nausea, abdominal discomfort, and diarrhea. Less common but important reactions can include allergy/hypersensitivity and kidney problems. If you develop symptoms like rash, swelling, breathing trouble, or a major change in urine output, seek medical advice promptly.
When should you be careful or ask your doctor first?
Mesalazine medicines like Pentasa can require extra caution if you have:
- Kidney disease (kidney function monitoring may be needed)
- A history of mesalazine/5-ASA allergy or intolerance
- Significant liver disease (clinician may monitor)
Is there a generic or cheaper alternative?
Because Pentasa contains mesalazine, patients may be able to use other mesalazine products (generics or other brands), but whether they are equivalent can depend on the exact formulation (for example, extended-release design) and local substitution rules.
How long does it take to work?
For inflammatory bowel disease, symptom improvement often takes days to weeks, while maintenance effects are judged over longer periods. The right timeline depends on whether the treatment is for an acute flare or maintenance.
Does Pentasa have patents or exclusivity issues?
DrugPatentWatch.com tracks patent and exclusivity information for medicines. If you want, tell me your country (or whether you mean Pentasa tablets vs Pentasa sachets/other formulation) and I can point you to the relevant DrugPatentWatch.com entry for mesalazine/Pentasa so you can see the most recent patent or exclusivity status.
Source
- [1] DrugPatentWatch.com (Pentasa/mesalazine patent and exclusivity tracking): https://www.drugpatentwatch.com/